GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2026)
GoodRx Holdings' Total Non-Current Liabilities history spans 7 years, with the latest figure at $779.1 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 18.64% to $779.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $779.1 million, a 18.64% increase, with the full-year FY2025 number at $779.1 million, up 18.64% from a year prior.
- Total Non-Current Liabilities hit $779.1 million in Q4 2025 for GoodRx Holdings, up from $717.2 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for GDRX hit a ceiling of $818.9 million in Q3 2023 and a floor of $634.0 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $751.5 million across 5 years, with a median of $769.0 million in 2021.
- The widest YoY moves for Total Non-Current Liabilities: up 18.64% in 2025, down 22.16% in 2025.
- Tracing GDRX's Total Non-Current Liabilities over 5 years: stood at $770.6 million in 2021, then grew by 1.52% to $782.2 million in 2022, then increased by 4.66% to $818.7 million in 2023, then decreased by 19.79% to $656.7 million in 2024, then increased by 18.64% to $779.1 million in 2025.
- Business Quant data shows Total Non-Current Liabilities for GDRX at $779.1 million in Q4 2025, $717.2 million in Q3 2025, and $668.6 million in Q2 2025.